DHR vs IDXX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
DHR · Danaher$230.25 ▲ 1.73%
IDXX · IDEXX Laboratories Inc$676.04 ▲ 0.79%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- DHR +9.6%
- IDXX -4.7%
Head to head
| Metric | DHR | IDXX |
|---|---|---|
| Price | $230.25 | $676.04 |
| Change today | ▲ 1.73% | ▲ 0.79% |
| Market cap | $161.99B | $53.26B |
| Return, 3 months | +10.0% | +13.5% |
| Return, year to date | +1.0% | -0.1% |
| Return, 1 year | +10.3% | -4.6% |
| P/E (TTM) | 37.7 | 45.6 |
| P/B | 3.0 | 28.5 |
| P/E percentile vs own 5y | 55th | 34th |
| Dividend yield | 0.66% | – |
| Revenue growth (YoY, latest qtr) | +8.3% | +9.7% |
| Net profit growth (YoY) | +36.0% | +15.1% |
| Gross margin | 58.6% | 62.4% |
| Operating margin | 20.4% | 32.0% |
| Net margin | 16.9% | 25.0% |
| Return on equity | 8.3% | 74.2% |
| Analyst target vs. price | +13.8% | +8.1% |
| Analyst buy share | 100% | 70% |
| RSI (14) | 54 | 71 |
| 30-day volatility | 31.9% | 64.7% |
| Max drawdown, 1 year | -33.0% | -34.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- DHR is the largest of the group by market value.
- DHR has returned the most over the past year.
- DHR carries the lowest trailing P/E.
- IDXX is growing revenue fastest.
- IDXX keeps the most profit per dollar of sales.
- DHR has been the calmest stock over the last 30 days.